1. (1) The Prescription Monitoring Program Advisory Commission is created for the purposes of:

   1. (a) Studying issues related to the prescription monitoring program established under ORS 431A.855;
   2. (b) Reviewing the program’s annual report and making recommendations to the Oregon Health Authority regarding the operation of the program; and
   3. (c) Developing criteria used to evaluate program data.

2. (2) The commission shall consist of 12 members appointed by the authority as follows:

   1. (a) A person nominated by the Pain Management Commission;
   2. (b) A person who dispenses controlled substances nominated by an association representing pharmacists;
   3. (c) A practicing dentist nominated by an association representing dentists;
   4. (d) A practicing doctor of medicine nominated by an association representing doctors of medicine;
   5. (e) A practicing doctor of osteopathic medicine nominated by an association representing osteopathic physicians and surgeons;
   6. (f) A nurse authorized to prescribe controlled substances nominated by an association representing nurses;
   7. (g) A practicing naturopathic physician nominated by an association representing naturopathic physicians;
   8. (h) A practicing optometrist, nominated by an association representing optometrists;
   9. (i) A representative of the authority with expertise in administering addiction services; and
   10. (j) Three members of the public, one of whom must be an expert in information technology.

[Formerly 431.976; 2017 c.409 §13; 2023 c.438 §7]